$22.64 0.14 (+0.62%)
11/6/2009 4:01 PM

Bristol-Myers Squibb Co. (BMY)

CAPS Rating: 5 out of 5

The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.

Recs

1
Member Avatar jvgarrison (55.38) Submitted: 6/14/2008 12:39:14 PM : Outperform Start Price: $18.55 BMY Score: +40.52

Another profitable company with a much above average dividend, and a potential takeover target due to its strong pipeline.

Report this Post 0 Comments

Featured Broker Partners